NC Lawmaker Pushes for FDA Regulation of Clinical Blood Tests
Congress is considering legislation to place more oversight on diagnostic lab tests currently not regulated by the Food and Drug Administration. Advocates and medical experts argued the legislation is needed to reduce false positives which can delay critical treatment for cancer patients. Mark Fleury, policy principal of emerging science for the American Center Action Network, said cancer patients in particular rely on molecular diagnostic tests. ...